Abstract:Background Elevated body mass index (BMI) has an adverse effect on cardiovascular riskfactors where diabetes and coronary artery disease increases with obesity. However, less in known about the prevalence and the grades of obesity in a diabetes population with acute myocardial infarction (AMI) and the impact on prognosis. Further, for the moment there is a shortage of access to cardioprotective weight loss medications as Glucagon Like Peptide Receptor Agonists (GLP-1 RA). Purpose To explore features and grades of obesity in patients with diabetes and AMI and impact on outcome in a national perspective. Methods All patients with diabetes and AMI admitted for coronary angiography in Sweden the years 2010-2021 were included. Information on BMI was collected at the time of angiography and grouped into obesity categories: low BMI (<18.5 kg/m2), normal BMI (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), obesity grade 1 (30.0-34.9 kg/m2), obesity grade 2 (35.0-39.9 kg/m2) and obesity grade 3 (≥40.0 kg/m2). Information on baseline characteristics and outcome was collected from national registries. Mortality was followed until March 2022. Restricted cubic spline analysis of association between continuous BMI and age-adjusted mortality was performed where normal BMI served as a reference with Hazard Ratio (HR) 1.0. Results Of 19 378 patients with diabetes, 67% were men and 46% suffered a STEMI. Normal BMI was present in 21%, overweight in 41%, obesity grade 1 in 25%, obesity grade 2 in 9% and obesity grade 3 in 3% (Figure 1). Age was decreasing with grade of obesity (72 years in normal BMI vs. 62 years in obesity grade 3, p<0.001). Hypertension and hyperlipidaemia were more common in patients with more severe obesity than in those with normal BMI (67% vs. 80%, p<0.001, and 44% vs. 50%, p<0.001, in normal BMI and obesity grade 3 respectively) while a higher proportion of those with normal BMI had suffered a previous MI (10% vs. 6% in obesity grade 3, p<0.001) and a previous stroke (10% vs. 5% in obesity grade 3, p<0.001). In patients with normal BMI STEMI was more common (51% vs. 39%, p<0.001) than in those with obesity grade 3. In patients with obesity grade 3 GLP-1 RA was used in 14% compared to 4% in those with normal BMI. Figure 2 depicts age-adjusted HR and 95% Confidence Interval for mortality for different BMI levels with a U-shaped pattern illustrating that associated mortality risk is higher when obesity is present especially grade 2 and 3. Conclusion Obesity is common affecting around one third of patients with diabetes and AMI and impacts survival. This strengthens that after AMI use of effective weight loss cardioprotective treatment should be prioritised in patients with diabetes and obesity especially if severe.

The Association between Body Mass Index and All-Cause Mortality in Type 2 Diabetic Inpatients With and Without Diabetic Microangiopathy—A Retrospective Cohort

The Impact of Diabetes on Mortality in Inpatients from Medical Department of A Chinese Tertiary Hospital

Body Mass Index and the Risk of All-Cause Mortality among Patients with Type 2 Diabetes Mellitus

Abstract 06: Body Mass Index and the Risk of All-cause Mortality among Patients with Type 2 Diabetes

Effect of body mass index on mortality for diabetic patients with aortic stenosis

Abstract 13759: Adherence to Healthy Lifestyle is Associated with Lower Total and Cause-Specific Mortality Risk among Patients with Diabetes: the UK Biobank Study

BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study

Adiposity and risks of vascular and non-vascular mortality among Chinese adults with type 2 diabetes: a 10-year prospective study

Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community-based prospective study

Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus

Body Mass Index and the Risk of Mortality among Chinese Adults with Type 2 Diabetes

Distribution of Lean Mass and Mortality Risk in Patients with Type 2 Diabetes.

Extent and impact of obesity in patients with diabetes and acute myocardial infarction - experience from a national cohort

Body Mass Index and Mortality Risk in Asian Peritoneal Dialysis Patients in Hong Kong—Impact of Diabetes and Cardiovascular Disease Status

Body Mass Index and Stroke Risk among Patients with Type 2 Diabetes Mellitus.

All-cause mortality and incidence of cardiovascular diseases in lean patients with newly diagnosed type 2 diabetes

Association between glycated hemoglobin and risk of all‐cause mortality in community patients with type 2 diabetes: A prospective cohort study

The coexistence of low muscle mass and obesity evaluated by dual energy X‐ray absorptiometry, rather than low muscle mass or obesity alone, is associated with macrovascular but not microvascular complications in patients with type 2 diabetes mellitus

Glycated Hemoglobin and All-Cause and Cause-Specific Mortality among Adults with and Without Diabetes.

Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: A dose–response meta-analysis

Association of Body Mass Index with All-Cause and Cardiovascular Disease Mortality in the Elderly